Unlock stock picks and a broker-level newsfeed that powers Wall Street.
KSE - Delayed Quote KRW

Daewon Pharmaceutical Co., Ltd. (003220.KS)

Compare
13,400.00
+160.00
+(1.21%)
At close: April 4 at 3:30:26 PM GMT+9
Loading Chart for 003220.KS
  • Previous Close 13,240.00
  • Open 13,080.00
  • Bid 13,270.00 x --
  • Ask 13,350.00 x --
  • Day's Range 13,080.00 - 13,540.00
  • 52 Week Range 13,080.00 - 20,700.00
  • Volume 24,756
  • Avg. Volume 122,851
  • Market Cap (intraday) 287.208B
  • Beta (5Y Monthly) 0.47
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 14, 2025 - May 19, 2025
  • Forward Dividend & Yield 300.00 (2.24%)
  • Ex-Dividend Date Dec 27, 2024
  • 1y Target Est 21,000.00

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 40 countries primarily in Asia, Central and South America, the Middle East, CIS, and Africa. The company was founded in 1958 and is headquartered in Seoul, South Korea.

www.daewonpharm.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 003220.KS

View More

Performance Overview: 003220.KS

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

003220.KS
5.96%
KOSPI Composite Index (^KS11)
2.75%

1-Year Return

003220.KS
6.49%
KOSPI Composite Index (^KS11)
10.09%

3-Year Return

003220.KS
20.97%
KOSPI Composite Index (^KS11)
10.61%

5-Year Return

003220.KS
12.98%
KOSPI Composite Index (^KS11)
42.89%

Compare To: 003220.KS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 003220.KS

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    287.21B

  • Enterprise Value

    428.34B

  • Trailing P/E

    17.91

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.43

  • Price/Book (mrq)

    1.04

  • Enterprise Value/Revenue

    0.72

  • Enterprise Value/EBITDA

    9.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.38%

  • Return on Assets (ttm)

    3.06%

  • Return on Equity (ttm)

    3.68%

  • Revenue (ttm)

    598.16B

  • Net Income Avi to Common (ttm)

    15.27B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    46.11B

  • Total Debt/Equity (mrq)

    65.80%

  • Levered Free Cash Flow (ttm)

    -28.2B

Research Analysis: 003220.KS

View More

Company Insights: 003220.KS

Research Reports: 003220.KS

View More

People Also Watch